Skip to main content
. 2020 Jun 22;13:82. doi: 10.1186/s13045-020-00911-4

Fig. 1.

Fig. 1

Clinical trials reporting MRD assessment. Results are based on a search in the https://clinicaltrials.gov/ website that included the terms “multiple myeloma” and “MRD.” Of 170 clinical trials, 154 indicate in the “descriptive information” that MRD is assessed. Furthermore, MRD negative rates are a “primary outcome measure” in 41 (27%) studies, and a “secondary outcome measure” in 104 (67%) trials